Adequate Clinical Trials of Immunotherapy
1982; Wiley; Volume: 37; Issue: 1 Linguagem: Inglês
10.1111/j.1398-9995.1982.tb04111.x
ISSN1398-9995
Autores Tópico(s)Food Allergy and Anaphylaxis Research
ResumoAllergyVolume 37, Issue 1 p. 1-14 Free Access Adequate Clinical Trials of Immunotherapy Kjell Aas, Corresponding Author Kjell Aas The Allergy Unit, Pediatric Research Institute, Rikshospitalet, University Hospital, University of Oslo, Oslo, NorwayK. Aas, The Allergy Unit Pediatric Research Institute Rikshospital Oslo 1 NorwaySearch for more papers by this author Kjell Aas, Corresponding Author Kjell Aas The Allergy Unit, Pediatric Research Institute, Rikshospitalet, University Hospital, University of Oslo, Oslo, NorwayK. Aas, The Allergy Unit Pediatric Research Institute Rikshospital Oslo 1 NorwaySearch for more papers by this author First published: January 1982 https://doi.org/10.1111/j.1398-9995.1982.tb04111.xCitations: 28AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL REFERENCES 1 Aas, K.: Immunotherapy of bronchial asthma. In L. M. Lich-tenstein & K. F. Austen (eds.): Asthma: physiology, immunopharmacology and treatment, pp. 385– 400. Academic Press, New York , 1977. 2 Aas, K., Backman, A., Belin, L. & Weeke, B.: Standardization of allergen extracts by appropriate methods The combined use of skin prick testing and radioallergosor-bent tests. Allergy. 33, 130– 137, 1978. 3 Aas, K.: Hyposensibilisierung. Wirkung und immunolo-gische Vorgehen. In K. Aas & H. D. Brede (eds.): Allergen-Extrakte. Arbeiten aus dem Paul-Ehrlich-Institut 73, 7– 15, 1979. 4 K. Aas (ed.): Materials and methods in allergy. Allergy. 35, 165– 261, 1980. 5 Aas, K.: Heterogeneity of bronchial asthma Subpopulations or different stages of the disease? Review Allergy. 36, 3– 14, 1981. 6 Aas, K.: The optimal allergen preparation for clinical use. In C. Steffen & H. Ludwig (eds.): Clinical immunology and allergology, pp. 255– 263. Elsevier/North-Holland, Amsterdam , 1981. 7 Aleong, J. & Bartlett, D. E.: Improved graphs for calculating sample sizes when comparing two independent binomial distributions. Biometrics. 35, 875– 881, 1979. 8 Altman, D. G.: Statistics and ethics in medical research. I. Br. Med. J. 281, 1182– 1184, 1980. 9 Altman, D. G.: Statistics and ethics in medical research. Br. Med. J. 281, 1267– 1269, 1980. 10 Altman, D. G.: Statistics and ethics in medical research. III. Br. Med. J. 281, 1336– 1338, 1980. 11 Alkman, D. G.: Statistics and ethics in medical research. VI. Br. Med. J. 281, 1399– 1401, 1980. 12 Altman, D. G.: Statistics and ethics in medical research. VII. Br. Med. J. 281, 1612– 1614, 1980. 13 Altman, D. G.: Statistics and ethics in medical research. Br. Med. J. 282, 44– 47, 1981. 14 Bluestein, J.: On children and proxy consent. T. Med. Ethics. 4, 138– 140, 1978. 15 Baer, H., Godfrey, H., Maloney, C. J., Norman, P. S. & Lichtenstein, L. M.: The potency and antigen E content of commercially prepared ragweed extracts. J. Allergy. 45, 347– 354, 1970. 16 Bernstein, J. L., Perera, M., Gallagher, J., Michall, J. G. & Johansson, S. G. O.: In vitro cross-allergenicity of major aeroallergenic pollens by the radioallergosorbent technique. J. Allergy Clin. Immunol. 57, 141– 152, 1976. 17 Boag, J. W., Haybittle, J. L., Fowler, J. F. & Emery, E. W.: The number of patients required in a clinical trial. Br. J. Radiol. 30, 371– 381, 1979. 18 Clark, C. J. & Downie, C. C.: A method for the rapid determination of the number of patients to include in a controlled trial. Lancet ii, 1357– 1358, 1966. 19 Cockburn, F., Dudgeon, J. A., Gairdner, D. M. T. & Jackson, A. D. M.: Guidelines to aid ethical committees considering research involving children. Arch. Dis. Child. 55, 75– 77, 1980. 20 Declaration of Helsinki, WHO Chronicle 30, 360– 362. 1976. 21 Editorial: Controlled trials: Planned deception Lancet i, 534– 535, 1979. 22 Engstrøm, I.: The bronchial provocation test and criteria for positive reaction. Allergy. 35, 256– 258, 1980. 23 Frostad, A. B., Grimmer, Ø., Sandvik, L. & Aas, K.: Hyposensitization. Comparing a purified (refined) allergen preparation and a crude aqueous extract from timothy pollen. Allergy. 35, 81– 95, 1980. 24 Hunt, K. J., Sobotka, A. K., Valentine, M. D., Yunginger, J. W. & Lichtenstein, L. M.: Sensitization following Hymenoptera whole body extract therapy. J. Allergy Clin. Immunol. 61, 48– 53, 1978. 25 Ishizaka, K. & Ishizaka, T.: Mechanisms of reaginic hypo-sensitivity and immunotherapy. Lung. 155, 3– 22, 1978. 26 Levine, K. J. & Lebacqz, K.: Ethical considerations in clinical trials. Clin. Pharmacol. Ther. 25, 728– 741, 1979. 27 Lichtenstein, L. M.: An evaluation of the role of immunotherapy in asthma. Am. Rev. Respir. Dis. 117, 191– 197, 1978. 28 Mygind, N.: Clinical investigations of allergic rhinitis and allied conditions. Allergy. 34, 195– 208, 1979. 29 Norman, P. S.: A review of immunotherapy. Allergy. 33, 62– 70, 1978. 30 Patterson, R.: Clinical efficacy of allergen immunotherapy. J. Allergy Clin. Immunol. 64, 155– 158, 1979. 31 Pepys, J.: Skin tests in diagnosis. In P. G. H. Gell, R. R. A. Coombs & P. J. Lachman (eds.): Clinical aspects of immunology, pp. 55. Blackwell, Oxford , 1975. 32 Peto, R., Pike, M. C., Armitage, P. et al.: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br. J. Cancer. 34, 585– 612, 1976. 33 Peto, R., Pike, M. C., Armitage, P. et al.: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br. J. Cancer. 35, 1– 39, 1977. 34 Rennie, D.: Vive la différence (p 0.05). New Engl. J. Med. 299, 828– 829, 1978. 35 Shuster, J. J., Binion, J., Moxley, J. et al.: Statistical review process. Recommended procedures for biomedical research articles. J. Am. Med. Assoc. 235, 534– 535, 1976. 36 Simmons, B.: Problems in deceptive medical procedures: An ethical and legal analysis of the administration of placebos. J. Med. Ethics. 4, 172– 181, 1978. 37 Taylor, G., MacNeil, A. R. & Freed, D. L. J.: Assessing degree of nasal potency by measuring peak expiratory flow rate through the nose. J. Allergy Clin. Immunol. 52, 193– 198, 1977. 38 Taylor, W. T., Ohman, K. L. & Lowell, F. C.: Immunotherapy in cat-induced asthma. Double-blind trial with evaluation of bronchial responses to cat allergen and histamine. J. Allergy Clin. Immunol. 61, 283– 287, 1978. 39 Turkeltaub, P. C., Marsch, D. G., Lichtenstein, L. M. & Norman, P. S.: Development of long-lasting immediate hypersensitivity in non-atopic volunteers parenterally immunized with a purified grass pollen extract. J. Allergy Clin. Immunol. (Abstracts), 61, 171, 1978. Citing Literature Volume37, Issue1January 1982Pages 1-14 ReferencesRelatedInformation
Referência(s)